OPHTEC-STABLEYES CAPSULAR TENSION RING

Ring, Endocapsular

FDA Premarket Approval P030023 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a new supplier of a critical raw material.

DeviceOPHTEC-STABLEYES CAPSULAR TENSION RING
Classification NameRing, Endocapsular
Generic NameRing, Endocapsular
ApplicantOPHTEC USA, INC.
Date Received2012-01-05
Decision Date2012-03-12
PMAP030023
SupplementS002
Product CodeMRJ
Advisory CommitteeOphthalmic
Supplement Type135 Review Track For 30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address OPHTEC USA, INC. 6421 Congress Ave., Suite 112 boca Raton, FL 33487

Supplemental Filings

Supplement NumberDateSupplement Type
P030023Original Filing
S008 2022-02-08 30-day Notice
S007 2018-12-18 30-day Notice
S006
S005 2016-06-10 30-day Notice
S004 2014-07-21 Normal 180 Day Track
S003
S002 2012-01-05 135 Review Track For 30-day Notice
S001 2011-10-19 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
08717819070286 P030023 004
08717819070279 P030023 004

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.